论文部分内容阅读
目的:分析和探讨采用酒石酸美托洛尔与卡托普利进行扩心病心力衰竭患者治疗的临床效果。方法:选取在我院心内科行70例扩心病心力衰竭患者为研究对象,随机分为2组,每组各35例,对照组施以常规药物治疗,观察组在对照组基础上给予酒石酸美托洛尔+卡托普利药物治疗,对比分析两组患者心室率、左室射血分数(LVEF)和6分钟步行测试(6mWT),对两组患者的运动耐量和心功能改善情况进行比较。结果:在LVEF、6mWT两个指标的比较中,观察组均明显较对照组高(P<0.05);在心室率指标的比较中,观察组明显较对照组低(P<0.05);观察组的治疗总有效率为97.1%,对照组为77.1%,两组比较差异显著(P<0.05)。结论:在扩心病心力衰竭患者的治疗中采用酒石酸美托洛尔与卡托普利进行联合治疗,能够使患者的运动耐量明显增强,心功能改善显著。
Objective: To analyze and discuss the clinical effects of metoprolol tartrate and captopril in the treatment of patients with heart failure with heart disease. Methods: Seventy patients with heart failure with heart disease in our department of cardiology were enrolled in this study. The patients were randomly divided into 2 groups (n = 35 in each group). The control group was given conventional drug treatment. The observation group was given tartaric acid To compare the ventricular rate, left ventricular ejection fraction (LVEF) and 6-minute walking test (6mWT) between two groups of patients, the comparison of exercise tolerance and cardiac function between the two groups was compared . Results: In the comparison of LVEF and 6mWT, the observation group were significantly higher than the control group (P <0.05); in the comparison of ventricular rate index, the observation group was significantly lower than the control group (P <0.05); observation group The total effective rate was 97.1% in the control group and 77.1% in the control group, with significant difference between the two groups (P <0.05). Conclusion: The combination of metoprolol tartrate and captopril in the treatment of patients with heart failure with heart disease can significantly improve the patient’s exercise tolerance and improve cardiac function.